Skip to content
  • Sunday, 26 July 2026
  • 1:08 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Michigan State University Researchers Identify Molecular Switch Powering Sperm Energy and Paving the Way for Non-Hormonal Male Contraception
Stem Cell & Regenerative Medicine

Michigan State University Researchers Identify Molecular Switch Powering Sperm Energy and Paving the Way for Non-Hormonal Male Contraception

Dwi Wanna Jul 13, 2026 0

In a breakthrough that could redefine the landscape of reproductive medicine, researchers at Michigan State University (MSU) have uncovered a…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis

Dwi Wanna May 7, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for a safe, reversible,…

Read More
Stem Cell & Regenerative Medicine

Molecular Switch Discovery in Sperm Metabolism Offers New Pathways for Infertility Treatment and Non-Hormonal Contraception

Dwi Wanna Apr 19, 2026 0

Researchers at Michigan State University (MSU) have identified a critical molecular "switch" that triggers a massive surge in sperm energy…

Read More
Study Hints at Clinical Lab’s Future Role in Investigating Sudden Unexplained Death in ChildrenBiogen Acquires RayThera for Up to $1 Billion to Bolster Immunology PipelineCornell University Scientists Achieve Breakthrough in Reversible Nonhormonal Male Contraception through Targeted Meiotic InterruptionMitochondrial Pearling: Unveiling the Hidden Mechanism Behind Cellular Energy Gene Distribution
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ